Literature DB >> 35286454

Nephrogenic diabetes insipidus with new onset diabetic ketoacidosis in a child - challenges in fluid and electrolyte management.

Yu-Shan Tseng1,2,3,4, Nicole Swaney5,6, Katherine Cashen7, Amrish Jain5,6, Nina Ma5,6, Andrew Prout5,6.   

Abstract

BACKGROUND: Intensive care management of diabetic ketoacidosis (DKA) is targeted to reverse ketoacidosis, replace the fluid deficit, and correct electrolyte imbalances. Adequate restoration of circulation and treatment of shock is key. Pediatric treatment guidelines of DKA have become standard but complexities arise in children with co-morbidities. Congenital nephrogenic diabetes insipidus (NDI) is a rare hereditary disorder characterized by impaired kidney concentrating ability and treatment is challenging. NDI and DKA together have only been previously reported in one patient. CASE DIAGNOSIS/TREATMENT: We present the case of a 12-year-old male with NDI and new onset DKA with hyperosmolality. He presented in hypovolemic shock with altered mental status. Rehydration was challenging and isotonic fluid resuscitation resulted in increased urine output and worsening hyperosmolar state. Use of hypotonic fluid and insulin infusion led to lowering of serum osmolality faster than desired and increased the risk for cerebral edema. Despite the rapid decline in serum osmolality his mental status improved so we allowed him to drink free water mixed with potassium phosphorous every hour to match his urinary output (1:1 replacement) and continued 0.45% sodium chloride based on his fluid deficit and replacement rate with improvement in his clinical status.
CONCLUSIONS: This case illustrates the challenges in managing hypovolemic shock, hyperosmolality, and extreme electrolyte derangements driven by NDI and DKA, as both disease processes drive excessive urine output, electrolyte and acid-base imbalances, and rapid fluctuation in osmolality.
© 2022. The Author(s), under exclusive licence to International Pediatric Nephrology Association.

Entities:  

Keywords:  Child; Diabetic ketoacidosis; Hyperosmolarity; Nephrogenic diabetes insipidus; Shock

Mesh:

Substances:

Year:  2022        PMID: 35286454     DOI: 10.1007/s00467-022-05436-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.651


  8 in total

1.  Treating hypernatremic dehydration.

Authors:  Andrew L Schwaderer; George J Schwartz
Journal:  Pediatr Rev       Date:  2005-04

2.  ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state.

Authors:  Joseph I Wolfsdorf; Nicole Glaser; Michael Agus; Maria Fritsch; Ragnar Hanas; Arleta Rewers; Mark A Sperling; Ethel Codner
Journal:  Pediatr Diabetes       Date:  2018-10       Impact factor: 4.866

Review 3.  Nephrogenic Diabetes Insipidus.

Authors:  Catherine Kavanagh; Natalie S Uy
Journal:  Pediatr Clin North Am       Date:  2019-02       Impact factor: 3.278

4.  Pediatric Diabetic Ketoacidosis With Hyperosmolarity: Clinical Characteristics and Outcomes.

Authors:  Sungeeta Agrawal; Grayson L Baird; Jose Bernardo Quintos; Steven E Reinert; Geetha Gopalakrishnan; Charlotte M Boney; Lisa Swartz Topor
Journal:  Endocr Pract       Date:  2018-08-07       Impact factor: 3.443

5.  Nephrogenic Diabetes Insipidus in Childhood: Assessment of Volume Status and Appropriate Fluid Replenishment.

Authors:  Stefano Guarino; Mario Diplomatico; Rosaria Marotta; Anna Pecoraro; Daniela Furlan; Lorenzo Cerrone; Emanuele Miraglia Del Giudice; Cesare Polito; Angela La Manna; Pierluigi Marzuillo
Journal:  Pediatr Emerg Care       Date:  2020-07       Impact factor: 1.454

6.  Sweet and Salty: Diabetic Ketoacidosis in a Patient With Nephrogenic Diabetes Insipidus.

Authors:  Hong A De Sa; Sunhee Chung; Paul M Shaniuk
Journal:  Cureus       Date:  2021-01-13

7.  Hypernatremic dehydration, diabetes insipidus, and cerebral venous sinus thrombosis in a neonate: a case report.

Authors:  Laurene M Fleischer; Thomas A Wilson; Margaret M Parker
Journal:  J Med Case Rep       Date:  2007-08-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.